---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-041884"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2023-11-17T23:59:59+00:00"
generated_at: "2026-06-08T00:25:41.681193+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ZyVersa receives Nasdaq delisting determination over low bid price; hearing requested

## Summary
- Nasdaq determined to delist on Nov 16, but company requested hearing, staying delisting pending panel decision.
- Stock closed at $0.10 or less for 10 consecutive days, triggering Low Priced Stocks Rule.
- Company had until Dec 6, 2023 to regain $1.00 bid compliance; low price accelerated delisting.
- Stockholders approved reverse stock split (1:10-1:50) at Oct 31 meeting; may be used to regain compliance.
- No assurance of favorable hearing outcome or extension; stock continues trading under ZVSA.

## SEC filing metadata
- accession: 0001493152-23-041884
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2023-11-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/0001493152-23-041884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-041884
- JSON: https://secwatch.observer/filing/0001493152-23-041884.json
- Plain text: https://secwatch.observer/filing/0001493152-23-041884.txt

## Key facts
- Listing & Compliance Notices
  ZyVersa Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)(iii)
  source text: November 14, 2023, Nasdaq issued a letter to the Company that as of November 13, 2023, it determined that the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Global Market, on November 16, 2023, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company has timely reque
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/0001493152-23-041884-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.